deltatrials
Completed OBSERVATIONAL NCT00911677

Does APOE-e4 Predict Delirium and Cognitive Dysfunction After Surgery?

Does Apolipoprotein E Genotype Predict Delirium and Postoperative Cognitive Dysfunction?

Sponsor: Canadian Anesthesiologists' Society

Updated 5 times since 2017 Last updated: May 29, 2009 Started: Aug 31, 2005 Primary completion: Mar 31, 2008 Completion: May 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Delirium and Postoperative Cognitive Dysfunction, this trial is completed. The trial is conducted by Canadian Anesthesiologists' Society and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotCompleted~Apr 2018 – ~Jan 2021 · 33 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Apr 2018 — Jan 2021 [monthly]

    Completed

    Phase: NANone

  5. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Canadian Anesthesiologists' Society
  • Ottawa Hospital Research Institute
  • University of Ottawa
Data source: Ottawa Hospital Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations